Sign in
Active, not recruitingNo phase

Fixation of OsseoTi™ Porous Structure Versus PPS (Porous Plasma Spray) Coating on the G7™ Acetabular Component for Primary Total Hip Arthroplasty

Key facts

Who runs it
Hvidovre University Hospital
Where
Denmark and Sweden2 sites in 2 countriesChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
98 people, planned
Started
Dec 2014
Expected to end
Apr 2027
Type of study
Interventional, 4 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • THA with G7 PPS coted acetabular component
  • THA with G7 OsseoTi coted acetabular component
Record updated
9 February 2021

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • • Participants with primary hip osteoarthritis set to receive a primary unilateral uncemented total hip arthroplasty; Participants must be 18-75 years of age; Participants must be able to speak and understand Danish (or depending on country where patient is enrolled); Participants must be able to give informed consent and be cognitively intact; Participants must be expected to be able to complete all postoperative controls; Participants must not have severe comorbidities, ASA-score ≤ 3

Who cannot take part

  • Previous fracture of the hip
  • Previous infection of the hip
  • Severe bony deformity warranting the use of non-standard implants
  • Terminal illness
  • Participants that develop deep infection in the follow-up period are excluded from the project
  • Rheumatoid arthritis
  • Osteonecrosis of the hip
  • Metastasis in the periarticular bone or proximal femur
  • Female patients that are pregnant or planning pregnancy during follow-up period
  • If bone stock or femoral canal type, assessed on preoperative x-ray, warrants the use of cemented fixation
  • Documented osteoporosis with patient in active medical treatment
  • Comorbidity with altered pain perception (e.g. DM with neuropathy)

This trial has no sites in United States.

It has sites in 2 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

The primary objective of this project is to investigate, using RSA, acetabular implant migration of the OsseoTi™ G7 acetabular cup in comparison to conventional PPS coated G7 acetabular cup, and compare liner wear of thinnest available E1™ liner, allowing for the largest possible femoral head (36mm-44mm) to E1™ liner holding a 32mm femoral head in the G7 acetabular system with endpoint assessment being performed at the 2 year follow-up.

The 4 groups in the trial

  • OsseoTi™ G7 largeExisting treatment, for comparison

    OsseoTi™ G7 acetabular cup and an E1™ liner holding largest possible femoral head (36mm-44mm)

    Treatment: THA with G7 PPS coted acetabular component and THA with G7 OsseoTi coted acetabular component

  • OsseoTi™ G7 32Existing treatment, for comparison

    OsseoTi™ G7 acetabular cup and an E1™ insert holding a 32mm femoral head

    Treatment: THA with G7 PPS coted acetabular component and THA with G7 OsseoTi coted acetabular component

  • conventional PPS coated G7 largeExisting treatment, for comparison

    conventional PPS coated G7 acetabular cup and an E1™ insert holding largest possible femoral head (36mm-44mm)

    Treatment: THA with G7 PPS coted acetabular component and THA with G7 OsseoTi coted acetabular component

  • conventional PPS coated G7 32Existing treatment, for comparison

    conventional PPS coated G7 acetabular cup and an E1™ insert holding a 32mm femoral head

    Treatment: THA with G7 PPS coted acetabular component and THA with G7 OsseoTi coted acetabular component

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Fixation of OsseoTi™ Porous Structure Versus PPS (Porous Plasma Spray) Coating on the G7™ Acetabular Component for Primary Total Hip Arthroplasty: A Single-Blinded Randomized Controlled Trial Evaluating Implant Migration, Acetabular Liner Wear, and Patient Reported Outcome
Record updated
9 February 2021